Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
about
Treatment for peritoneal dialysis-associated peritonitisTreatment for peritoneal dialysis-associated peritonitisAssociation between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageMultidrug-resistant Acinetobacter baumanniiConfounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisitionTreatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patientsPrior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilitiesA comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.Enterococcus faecalis prophage dynamics and contributions to pathogenic traitsAntimicrobial Use and Resistance.Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiotaIn vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteriaEpidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital.Viral warts in organ transplant recipients: new aspects in therapy.Reference group choice and antibiotic resistance outcomes.Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.Resistance to antimicrobial agents: an update.Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States.Laboratory-based evaluation of MDR strains of Pseudomonas in patients with acute burn injuriesGuidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistanceCausative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.Longer intestinal persistence of Enterococcus faecalis compared to Enterococcus faecium clones in intensive-care-unit patients.Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.Role of matching in case-control studies of antimicrobial resistance.BReast Ecology Assessment in the STudy of local MicroFlora - Study Protocol.Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study.The role of antimicrobial stewardship in curbing carbapenem resistance.Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers.
P2860
Q24195002-38A170B8-A201-45B6-9040-143F0838E1C3Q24242227-456AD4D8-B08C-4C4D-8C70-CD572558B045Q28268161-697C2E47-82A9-4B62-8635-3D5C614F6D94Q28306885-85FCC148-7DFD-417B-A395-CF4BD4B87F27Q33756510-25508C5E-D908-44AF-8596-5350942CCD63Q33826293-426BB8DE-79A3-4ADE-8899-5DD9646994F5Q33880518-1FA1660A-6EF9-43EA-BF43-CD0D883D723EQ33978474-A0152A6D-CEC2-45E2-8BAD-F68959BD66B9Q34123634-DE9999E0-E4F8-4A16-8F78-939F55DD493FQ34175284-692A0A1E-6842-4502-B710-F3AA54B62C32Q34301559-45B47B03-D23C-4A6C-A323-59156B70D6CAQ34640030-C7BE1C21-1F32-4403-988E-3FB7BF89F39AQ34643123-3CF9B64B-ECA4-409F-A929-562182EE3A99Q34765413-82B3B426-6CAC-48B7-AA40-83F68E2CFCE6Q34998303-9E1CDA25-0987-49A8-8B6B-58E4E8DD12AAQ35069150-AFC3E7B0-C2DD-402D-9283-730D854F1005Q35103522-6FBC6B4A-D7BF-4C3D-A239-130D52E35901Q35414615-40ECA765-4F3F-4615-AAA9-F0CC34F146AFQ35583156-5A5C0645-EA7C-48C4-B137-43B321652BF9Q35880537-A83C5DE7-45D3-4AD6-87EA-597E63B059B0Q35908101-38B0212A-03F8-4ACE-B213-3A29DC3C9E27Q35976850-618CCFAE-A645-4F7B-86B2-31B86CD2A8A3Q36009339-9423B3CB-89D4-4662-83B0-2B048740DE72Q36318055-F31A7CC8-B0E6-443D-85F5-B9194E7B48EAQ36409465-6B7E0BD7-9196-41E2-96EA-FF8CAB0F6ACDQ36474366-16DBF36D-BB43-448A-BF71-2F20F984DCB8Q36505351-2B34FD73-F990-41FF-B1B9-8EAB92F297A8Q36757737-37CEAE35-AE4A-4823-BF2B-1F57018C87CBQ36973200-B3BC7054-A1B9-48E5-90FE-D7E59F1737FEQ37099648-C0DD3AB8-5345-4067-8DA5-B0B5190FC14DQ37346968-F519FAAF-3146-4742-A33B-258A4FC5F902Q37399052-0C58DD7C-E94D-4B40-8F36-8AB48CD97DFCQ37441552-C3FCAB51-2687-408B-9CC9-5D7039510670Q37539680-55500E6C-8956-41B3-B966-C5C6CEC19F9CQ38049612-FC43514D-C31D-451A-8CD1-19A01D5BF21AQ38125493-26D803E0-6019-4A4A-B4E1-CAE19C9E93A5Q38126225-6C9D8AA4-82B7-436B-8B03-3B47CC0436B9Q38461269-93E39519-4EFD-404C-85E7-155A62EC9AD8Q40828436-B56976FD-743C-4B70-B7C5-0A95A677FDD1Q42211167-EFFC3298-97C9-4FB6-B628-AB3EB2F87D8D
P2860
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@en
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@nl
type
label
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@en
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@nl
prefLabel
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@en
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@nl
P2093
P2860
P356
P1476
Antecedent treatment with diff ...... omycin-resistant Enterococcus.
@en
P2093
George M Eliopoulos
Matthew H Samore
Yehuda Carmeli
P2860
P304
P356
10.3201/EID0808.010418
P577
2002-08-01T00:00:00Z